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Introduction: Sleep deprivation is common in critically ill patients in the intensive care unit (ICU). Noise and light in
the ICU and the reduction in plasma melatonin play the essential roles. The aim of this study was to determine the
effect of simulated ICU noise and light on nocturnal sleep quality, and compare the effectiveness of melatonin and
earplugs and eye masks on sleep quality in these conditions in healthy subjects.
Methods: This study was conducted in two parts. In part one, 40 healthy subjects slept under baseline night and
simulated ICU noise and light (NL) by a cross-over design. In part two, 40 subjects were randomly assigned to four
groups: NL, NL plus placebo (NLP), NL plus use of earplugs and eye masks (NLEE) and NL plus melatonin (NLM).
1 mg of oral melatonin or placebo was administered at 21:00 on four consecutive days in NLM and NLP. Earplugs
and eye masks were made available in NLEE. The objective sleep quality was measured by polysomnography.
Serum was analyzed for melatonin levels. Subjects rated their perceived sleep quality and anxiety levels.
Results: Subjects had shorter total sleep time (TST) and rapid eye movement (REM) sleep, longer sleep onset
latency, more light sleep and awakening, poorer subjective sleep quality, higher anxiety level and lower serum
melatonin level in NL night (P <0.05). NLEE had less awakenings and shorter sleep onset latency (P <0.05). NLM had
longer TST and REM and shorter sleep onset latency (P <0.05). Compared with NLEE, NLM had fewer awakenings
(P = 0.004). Both NLM and NLEE improved perceived sleep quality and anxiety level (P = 0.000), and NLM showed
better than NLEE in perceived sleep quality (P = 0.01). Compared to baseline night, the serum melatonin levels were
lower in NL night at every time point, and the average maximal serum melatonin concentration in NLM group was
significantly greater than other groups (P <0.001).
Conclusions: Compared with earplugs and eye masks, melatonin improves sleep quality and serum melatonin
levels better in healthy subjects exposed to simulated ICU noise and light.
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Sleep deprivation is a major concern in critically ill pa-
tients in the ICU, and is characterized by poor subjective
sleep quality, a paucity of restorative sleep stages and loss
of circadian rhythms. [1] Because of frequent arousals and
awakenings, sleep in the ICU has a higher proportion of
none-rapid eye movement (NREM) sleep stage 1 and 2 (or
light sleep), and reduced restorative slow wave (SW) and
rapid eye movement (REM) sleep [2], and might bring
many adverse consequences, including impaired immune
function, difficult weaning from mechanical ventilation,
delirium and severe morbidity [3].
The cause of sleep disturbance in the ICU is multifac-
torial. Aside from the primary diseases, medications,
mechanical ventilation and so on, ICU noise and light
environment, and hormonal imbalance play essential
roles [4-8]. Gabor et al. reported that ICU noise and pa-
tient care activities were responsible for up to 30% of
the arousals and awakenings in ICU patients [9]. Some
studies also found that ICU noise or/and light might in-
crease the sleep-onset latency, shorten total sleep time
and disturb sleep structure in healthy subjects [6,10,11].
Hu et al. suggest that ICU noise and light might disturb
sleep by suppressing nocturnal melatonin levels [6].
Therefore, the ICU environment is a critical factor that
causes ICU sleep disturbance, which can be relatively easy
to control and diminish, in contrast to most other factors.
Currently, there are many strategies for ICU acousto-
optic control, such as controlling noise and dimming the
light at night and large-scale ICU environmental reform
and so on, but the low universality and poor feasibility
are the major problems [12]. Therefore, some domestic
and international experts recommend that ICUs incorpor-
ate earplugs/eye masks into routine nursing care: however,
effectiveness is still a matter of debate [13]. Hu et al.
found earplugs and eye masks might elevate the nocturnal
melatonin level when tested in healthy subjects in a simu-
lated ICU environment [6]. However, most critically ill pa-
tients in the ICU lose their ability to regulate melatonin
secretion by exposure to darkness and light. [14] There-
fore, more effective strategies for improving sleep disrup-
tion induced by ICU noise and light are urgently needed.
Melatonin is a substance with pleiotropic physiologic
action synthesized in the pineal gland [15]. Its secretion
is suppressed by light and stimulated by darkness [15].
The disruption to the normal timing and amplitude of
the circadian rhythm of melatonin secretion is associated
with disturbed sleep [16,17]. Exogenous melatonin has
been demonstrated to be safe and effective in the treat-
ment of primary insomnia in the elderly and other circa-
dian rhythm sleep disorders [18-22]. Recently several
studies found melatonin levels in critically ill patients to
be severely depressed [23-27], which raised interest in
melatonin as a potential therapeutic or prophylactic agentin the management of ICU sleep disturbance. However,
until now the influence of melatonin treatment on sleep
quality in ICU patients remained controversial [28-30].
No studies have yet evaluated the effects on sleep in ICU
patients of oral melatonin, as measured by polysomnogra-
phy (PSG), the gold standard for assessing sleep quality.
However, critically ill patients have disturbed electroen-
cephalographic patterns caused by many complex factors
as seen in sepsis, neurologic pathology and medication,
among others, and the sleep staging in accordance with
the American Association of Sleep Medicine 2007 criteria
cannot be met [31]. Therefore, in our study we recruited
healthy participants as experimental subjects and con-
ducted the research in a simulated ICU environment,
and adopted the gold standard assessment technique to
verify our hypothesis. Meanwhile, the comparative study
of different strategies for addressing the problem of ICU
sleep disturbance has not been performed. In this study,
we aimed to investigate and compare the effectiveness
of oral melatonin, and wearing of earplugs and eye
masks, on sleep quality in healthy subjects who were ex-
posed to a simulated ICU situation.
Materials and methods
Study design and participants
The study protocol was formally approved by the Institu-
tional Review Board of Fuzhou Children’s Hospital (ap-
proval number 2014–001) and by the Chinese Clinical
Trial Registry (approval number ChiCTR-IPR-14005458).
The study was carried out in accordance with the Declar-
ation of Helsinki principles. All participants provided writ-
ten informed consent. Subjects were included in the study
if they were older than 18 years of age, had body mass
index (BMI) <26 kg/m2, were non-smokers, had scores ≤7
on the Pittsburgh sleep quality index (PSQI), had almost
had no daytime sleep and slept only at night, that is, they
went to bed between 21:00 and midnight and habitually
spent in between 6 and 9 h per night in bed. Exclusion cri-
teria included a history or current diagnosis of other sleep
disorders (such as restless leg syndrome, periodic leg
movements with arousals, narcolepsy, REM behavior
disorder, circadian rhythm sleep disorder, breathing-
related sleep disorder, or parasomnia), which was
assessed by the clinical manifestation and a diagnostic
PSG record (which was also performed to familiarize sub-
jects with the PSG procedures); reduced hearing acuity
(>20 dB hearing loss at a single frequency, as tested with
an audiometer (Entomed SA 201); blindness (as tested
with visual testing and perimetry), and a history of alcohol
or medication abuse. Participants with an occupational
history that included shift work or recent significant travel
across three or more time zones within the prior two
weeks were also excluded. In addition, after a screening
PSG, participants with an apnea-hypopnea index >15 or a
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lergy to melatonin, were also excluded.
All healthy participants (n = 40) slept in individual private
rooms for eight nights (21:00 to 06:00) (Figure 1). The first
night served as adaptation, that is, the participants followed
the same procedure and data (not to be used in the ana-
lyses) were collected just as in the following nights. Then,
the study was conducted in two stages. The first stage used
a crossover design to investigate the impact of ICU noise
and light environment on the sleep quality of healthy sub-
jects. To minimize order effects, half of the healthy subjects
(n = 20) were randomly exposed to a simulated ICU noise
and light (NL) environment on the second night and to a
quiet and dark environment (baseline) on the third night.
In the meantime, other participants (n = 20) were exposed
in the opposite order. In this stage, all subjects underwent
two overnight PSG examinations on the second and third
nights. For each subject, study nights were spaced 3 days
apart to avoid delay effects. The second stage was to
evaluate the effect of melatonin, and earplugs and eye
masks, on the sleep quality of healthy subjects exposed to
simulated nocturnal ICU noise and light. These 40 partici-
pants were assigned randomly to either: (1) simulated ICU
noise and light (NL); (2) NL plus placebo (NLP); (3) NL
plus melatonin (NLM); or (4) NL plus use of earplugs and
eye masks (NLEE) in a 1:1:1:1 ratio.
Randomization was performed using a computer-
generated schedule independent of treatment personnel.
Subjects in the melatonin and placebo groups did not know
they were receiving active therapy, nor did their clinicians.
As potential chronophypnotic benefits of melatonin are notFigure 1 Study design.immediate and may take at least 3 days to be released, the
process of intervention should take 4 days [28-30]. In order
to control for possible effects of baseline values on the out-
come variable, the baseline data for the simulated ICU en-
vironment (BaselineNL) needed to be collected and
analyzed before the 4-day intervention. Therefore, in this
stage, all participants slept in the simulated ICU noise and
light environment during the fourth night, and were ex-
posed to corresponding intervening factors based on their
group assignment for the following four consecutive nights
(fifth to eight night) in the laboratory, and underwent two
nighttime PSG evaluations on the fourth night for the base-
line, and on the eighth night for assessment of the outcome
variable, respectively.
Intervention and instruments
Baseline night (quiet and dark environment)
The laboratory is constructed so that sounds or vibrations
from the surroundings are completely prevented and the
background noise level with full ventilation is less than
15 dB (A). The dB(A) means that the sound level is mea-
sured by A weighting sound level meter. Mean nighttime
light levels in the sleep laboratory measured 5 lux with the
light off and the door to the hallway shut. Therefore, on
the baseline night, all healthy subjects slept in a quiet en-
vironment with the light off.
Simulated ICU noise and light night (NL night)
Simulated ICU noise exposure
The exposure sounds in our study were recorded digit-
ally during a typical weekday night shift (21:00 to 06:00)
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puter for playback in the sleep laboratory. ICU noise was
continuously monitored during the night using a sound
meter, model AW5610D (AWAI, Hangzhou, China) in the
surgical ICU (SICU) environments. The SICU had noise
levels far exceeding the 20 dB (A) at nighttime recom-
mended by the Guidelines of the Chinese Association of
Critical Care medicine (2006). The mean (standard devi-
ation) noise value in the SICU was 67.1 ± 10.2 dB (A), the
peak noise level recorded was 99.7 dB (A), and the minimal
noise level recorded was 47.3 dB (A). The sound recording
equipment, model ICD-P320 (Sony Inc., Tokyo, Japan),
was positioned at the bed of patients receiving mechanical
ventilation. Simultaneous sound meter readings were taken
to ensure similar noise levels during playback in the sleep
laboratory.
Simulated ICU lighting conditions
Nighttime illumination in the ICU setting and the sleep
laboratory were monitored by a light detector model
TES1332 (Taiwantes, Shenzhen, China). In both settings,
the main light was provided by fluorescent ceiling lights.
The light detector was placed by a patient receiving mech-
anical ventilation, but not so as to interfere with patient
care. Light measurements were taken every hour during
the night. In the ICU high mean night light levels ranging
between 56.0 and 221.3 lux were maintained. The mean
nighttime light level in the sleep laboratory measured 100
lux with the light on, and 5 lux with the light off and the
door to the hallway shut. Therefore, the study used 100
lux to simulate the ICU lighting conditions.
During BaselineNL, NL, NLM, NLEE and NLP nights,
recorded ICU noise was played and the fluorescent lights
were turned on in the sleep laboratory. A sound meter
was placed at the head of the subject’s bed and the record-
ing time synchronized with the sound meter to ensure
playback in a similar range of decibels to that recorded.
Earplugs and eye masks (NLEE night)
Subjects were instructed to wear earplugs with a 29-dB
noise reduction rating (3 M Corporation, Beijing, China)
and eye masks during the NLEE night. Subjects chose
from three sizes of eye mask provided, which were 18 ×
6 cm, 21 × 8 cm, and 24 × 10 cm, respectively. All partic-
ipants chose the most suitable size according to their
face size. We offered earplugs and eye masks to the sub-
jects at night (from 21:00 to 06:00).
Melatonin (NLM)
Participants assigned to the melatonin group were given
a 1-mg fast-release oral dose of melatonin (Armonia®
Retard 1 mg; Nathura, Montecchio Emilia, Italy) adminis-
tered at approximately 21:00. Dose changes were not per-
mitted. Melatonin is not a licensed drug in China, and it issold as a food supplement in a variety of preparations.
The product used in this study contains a high-purity
melatonin preparation (99.9%). This product has been
regularly registered in the list of food supplements of the
Italian Ministry of Health (cod. 08 29284 Y).
Placebo (NLP)
Participants in this group were treated according to a
protocol identical to those receiving active medication.
As with melatonin, the placebo was made in the identical
formulation, and there were no differences in appearance,
smell or flavor between the active and inactive pills.
Sleep measures and laboratory test
Polysomnography
Sleep was assessed by PSG using the Polysmith 2003 sleep
acquisition and analysis system (Neurotronics, Gainesville,
FL, USA). The standard procedure for sleep measurement
described by Rechtschaffen and Kales was followed [32].
Subjects were hooked up for recording of an electro-
encephalogram (EEG), eye movement, and a submental
electromyogram (EMG) in the sleep laboratory. Electrode
impedances were within acceptable limits (<10 kQΩ).
PSG equipment was located outside the subject’s room.
Sleep variables (sleep period time, sleep efficiency index,
sleep-onset latency, REM latency, arousal index and
percentage of sleep in REM, stage one, two and three
and so on) were scored manually and independently by
two scorers who were unaware of the experimental con-
ditions, according to standardized criteria. Polysomno-
graphic records were collected from 21:00 to 06:00 on
nights 1 to 4 and on night 8.
Serum melatonin concentration
Nocturnal blood was collected at 20:50 (before adminis-
tration), 22:00, 23:00, 24:00, 01:00, 02:00, 03:00, 04:00,
05:00 and 06:00 h on nights 2, 3 and 8. In order to avoid
repeated venipuncture, it is routine to give all subjects
an indwelling vein needle. The trained technicians were
required to access the participant’s room as quietly as
possible and take blood by the light of an electric torch.
Blood samples were collected in plastic tubes without
anticoagulant agents and stored at −20°C until assayed.
Melatonin concentrations were measured using a com-
mercial radioimmunoassay (RIA) kit for human melatonin
(BioSource Europe SA, Belgium). In this assay, sensitivity
was 2 pg/mL. The intra-assay and inter-assay coefficients
of variation (CV) were 5.6% and 8.2%, respectively.
Subjective measurements
Subjective sleep quality was assessed by a visual analog
scale developed by the researchers based on previous scales
[33]. Subjects evaluated their sleep quality on a scale of 0
to 10 (0 = excellent, 10 = poor) at 7:00 am on the morning
Huang et al. Critical Care  (2015) 19:124 Page 5 of 11after nights 2, 3, 4 and 8, with a higher score indicating
poorer habitual sleep quality.
State anxiety level was assessed at 7:00 am on the
morning after nights 2, 3, 4 and 8. In our study, the
Spielberger state anxiety inventory (SAI) was chosen be-
cause it provides evaluation of state anxiety levels, namely
a temporary unpleasant emotional arousal in the face of
threatening demands or dangers. Subjects rated their feel-
ings of anxiety on a 4-point scale ranging from a score of
1 (almost never anxious) to 4 (almost always anxious), a
higher score indicating a higher anxiety level.
Subjects were asked to evaluate the comfort, effective-
ness and ease of use of earplugs and eye masks on the
morning after the NLEE night, using a 5-point scale ran-
ging from a score of 1 (very uncomfortable, very unhelp-
ful, very awkward) to 5 (very comfortable, very helpful,
very easy to use), with low scores indicating a less pleas-
ant experience.
Statistical analysis
Data were analyzed using SPSS version 19.0 (SPSS Inc.,
Chicago, IL, USA). Data for the adaptation night were
excluded from analysis because the first night of sleep in
a sleep laboratory room with unfamiliar surroundings dif-
fers from sleep on subsequent nights [18]. All data were
expressed as mean ± SD. One-way analysis of variance
(ANOVA) was used to determine differences in perceived
sleep quality and anxiety levels during the four nights of
the experiment. The ANOVA for repeated measures can
be used to determine differences in sleep variables and
melatonin concentrations during the four nights of the
experiment. The paired Student t-test or non-parametricTable 1 Characteristics of healthy subjects in the baseline nig
Variable NI NIP
Age 42.8 ± 11.8 39.7 ± 11
Gender (percent female) 0.4 0.5
Time in bed (min) 520.6 ± 17.0 509.1 ± 1
Total sleep time (min) 349.2 ± 28.4 354.0 ± 2
Sleep efficiency index 0.69 ± 0.08 0.75 ± 0.0
REM (%) 16.6 ± 3.6 16.5± 6.3
N1 (%) 17.7 ± 3.9 18.8 ± 3.3
N2 (%) 47.9 ± 6.3 47.5 ± 7.1
N3 (%) 15.8 ± 3.5 17.2 ± 4.9
Sleep onset latency (min) 58.4 ± 15.5 54.3 ± 15
REM latency (min) 166.6 ± 38.8 140.4 ± 2
No. of awakenings 14.4 ± 3.3 14.4 ± 3.1
Sleep arousals index 8.7 ± 3.3 8.4 ± 2.4
State anxiety 46.0 ± 8.8 45.2 ± 7.7
Sleep quality 6.1 ± 1.0 5.9 ± 1.0
NL: simulated ICU noise and light; NLP: NL plus placebo; NLM: NL plus melatonin; NWilcoxon rank sum test were performed to evaluate the
effect of melatonin, and earplugs and eye masks on sleep
variables and melatonin secretion during exposure to sim-
ulated ICU sound and light, where appropriate. The chi-
square test was used to compare the gender ratio. P <0.05
was considered significant.
Results
Forty healthy subjects were recruited. All 40 subjects (20
female and 20 male, aged 24 to 64 years, mean 41.2 ±
11.8 years) completed the study. The average habitual
sleep time of the participating subjects was 7.1 h (SD
0.5 h), with an average habitual time of retiring of 22:05
and of getting up of 06:25. In part 2 of the study, the re-
sults were based on the following numbers of subjects:
10 in NL, 10 in NLP, 10 in NLEE and 10 in NLM.
Notably, there were no significant differences in the
demographic characteristics and clinical variables of the
subjects at the baseline of simulated ICU noise and
light (BaselineNL) for the different study conditions (all
P >0.05) (Table 1).
Sleep architecture
The influence of simulated ICU noise and light on sleep
architecture of healthy subjects compared to the baseline
night are shown in Table 2. Compared to baseline, total
sleep time, sleep efficiency index and the mean percent
REM sleep were reduced during the NL night (P = 0.000,
P = 0.001 and P = 0.006, respectively). The sleep-onset
latency, number of awakenings, sleep arousals index and
the mean percent stage 2 non-REM (NREM) sleep were
increased during the NL night compared to baseline (P =ht of simulated ICU noise and light (BaselineNL)
NLEE NLM P
.6 40.1 ± 12.7 42.0 ± 12.8 0.930
0.5 0.6 0.849
6.4 511.8 ± 17.8 510.9 ± 26.6 0.580
2.6 354.2 ± 20.7 348.6 ± 22.0 0.922
8 0.72 ± 0.07 0.75 ± 0.05 0.164
18.5 ± 3.5 19.3 ± 4.1 0439
19.6 ± 2.3 19.6 ± 3.2 0.530
46.2 ± 1.6 43.6 ± 3.4 0.259
15.7 ± 2.8 17.5 ± 3.5 0.620
.3 53.2 ± 16.9 46.9 ± 11.0 0392
9.3 159.5 ± 30.0 154.4 ± 37.5 0381
13.5 ± 2.8 13.8 ± 3.0 0.885
8.2 ± 1.3 8.4 ± 2.1 0.981
44.4 ± 5.9 45.0 ± 5.9 0.968
6.1 ± 1.3 6.2 ± 1.4 0.952
LEE: NL plus use of earplugs and eye masks.
Table 2 Comparison of sleep architecture between
baseline night and simulated ICU noise and light night
Variable Baseline NL P
Time in bed (min) 507.8 ± 21.1 509.6 ± 23.7 0.860
Total sleep time (min) 424.3 ± 25.9 359.2 ± 39.9 0.000
Sleep efficiency index 0.83 ± 0.06 0.71 ± 0.08 0.001
REM (%) 21.9 ± 3.8 15.8 ± 4.8 0.006
N1 (%) 19.6 ± 3.8 19.7 ± 9.8 0.983
N2 (%) 39.8 ± 5.1 47.8 ± 8.3 0.018
N3 (%) 18.7 ± 5.3 14.7 ± 4.2 0.078
Sleep onset latency (min) 23.4 ± 10.1 66.2 ± 20.7 0.000
REM latency (min) 147.8 ± 20.1 163.9 ± 55.2 0.399
No. of awakenings 9.9 ± 3.7 14.4 ± 3.3 0.011
Sleep arousals index 5.0 ± 1.8 8.7 ± 3.3 0.006
Baseline: quiet and dark environment; NL: simulated ICU noise and light.
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Mean stages 1 and 3 NREM sleep percentage and REM
latency during the night were not different between
conditions.
Results of sleep variables during NL, NLP, NLM and
NLEE nights are shown in Table 3. Repeated measures
ANOVA showed that sleep architecture changed signifi-
cantly by condition in the percentage of REM sleep (P =
0.05), sleep-onset latency (P = 0.001), number of awak-
enings (P = 0.000) and sleep arousals index (P = 0.000).
Comparison of sleep variables during exposure to the
simulated ICU environment indicated that use of ear-
plugs and eye masks resulted in fewer awakenings (P =
0.001), shorter sleep-onset latency (P = 0.01) and less
sleep arousal according to the sleep arousal index (P =
0.000). Comparison of sleep variables during exposure
to the simulated ICU environment indicated that use ofTable 3 Comparison of sleep architecture in simulated ICU no
Variable NL NLP NLEE
Time in bed (min) 513.8 ± 18.6 507.3 ± 23.0 507.9 ± 29.7
Total sleep time (min) 369.0 ± 35.0 367.6 ± 33.3 385.8 ± 38.9
Sleep efficiency index 0.72 ± 0.08 0.72 ± 0.07 0.76 ± 0.08
REM (%) 16.0 ± 4.2 15.0± 7.6 18.4 ± 3.7
N1 (%) 20.3 ± 8.6 21.1 ± 8.7 20.4 ± 3.2
N2 (%) 46.8 ± 7.3 47.4 ± 7.6 46.3 ± 3.0
N3 (%) 15.0 ± 3.9 16.5 ± 4.5 14.9 ± 3.1
Sleep onset latency (min) 71.4 ± 25.6 61.3 ± 20.6 46.6 ± 21.6
REM latency (min) 154.4 ± 46.9 158.2 ± 39.2 158.0 ± 37.4
No. of awakenings 15.1 ± 3.3 13.0 ± 3.1 10.5 ± 3.2
Sleep arousals index 9.8 ± 3.0 8.2 ± 2.6 5.5 ± 2.1
NL: simulated ICU noise and light; NLP: NL plus placebo; NLM: NL plus melatonin; N
2: NLP vs. NLM; Contrast 3: NLEE vs. NLM.melatonin resulted in more total sleep time (P = 0.043),
greater percentage of REM (P = 0.011), fewer awaken-
ings (P = 0.000), shorter sleep-onset latency (P = 0.004)
and less arousal according to the sleep arousal index (P =
0.001). No differences were found between use of earplugs
and eye masks, and use of melatonin, in most of sleep
variables except the number of awakenings (P = 0.004),
during exposure to the simulated ICU environment (all
P >0.05), although the sleep variables showed interesting
trends towards better sleep on the NLM night than on
the NLEE night.
Serum melatonin level
The influence of simulated ICU noise and light on
nocturnal serum melatonin levels in healthy subjects
compared to the baseline night are shown in Figure 2.
Both on baseline and on NL nights, endogenous
melatonin secretion followed a similar circadian pat-
tern, with the rise in melatonin levels at around 20:50
(before bedtime), reaching peak concentration at
03:00 and 04:00, respectively, and then gradually
dropped. However, compared to the baseline night,
the serum melatonin levels were lower on the NL
night at every time point. There were significant dif-
ferences between the two groups at the following
time points: 0:00, 01:00, 02:00, 03:00 and 04:00 (all P
< 0.05).
Nocturnal serum melatonin levels during the NL, NLP,
NLM and NLEE nights are shown in Figure 3. NL, NLP
and NLEE had the similar circadian pattern with the rise
in melatonin levels at around 20:50 (before bedtime),
reaching peak concentration at 04:00, 04:00 and 03:00,
respectively. However, in the NLM group, melatonin
was rapidly absorbed following oral ingestion in all the
subjects in the NLM group. Maximal melatoninise and light night for different study conditions
NLM ANOVA Contrast 1 Contrast 2 Contrast 3
P P P P
508.8 ± 26.5 0.934 0.598 0.893 0.936
401.2 ± 35.8 0.137 0.302 0.043 0.342
0.79 ± 0.11 0.186 0.273 0.077 0.396
20.9 ± 3.0 0.050 0.285 0.011 0.258
19.2 ± 4.0 0.928 0.973 0.509 0.681
42.6 ± 3.5 0.262 0.850 0.073 0.161
17.3 ± 3.6 0.425 0.991 0.654 0.175
33.7 ± 10.5 0.001 0.010 0.004 0.163
149.5 ± 37.8 0.959 0.844 0.634 0.644
6.5 ± 1.8 0.000 0.001 0.000 0.004
4.5 ± 1.4 0.000 0.000 0.001 0.392
LEE: NL plus use of earplugs and eye masks; Contrast 1: NL vs. NLEE; Contrast
Figure 2 Melatonin levels in healthy subjects on the baseline
night and on the simulated ICU noise and light (NL) night.
Serum melatonin levels were measured in all subjects on baseline
and NL nights for 9 h from 20:50 to 06:00. The graph depicts the
nocturnal serum melatonin concentration. Points represent mean ± SD.
Solid circles, healthy subjects on the baseline night; solid triangles,
healthy subjects on the NL night: *P <0.05 at 0:00, 01:00, 02:00, 03:00
and 04:00 for comparison of the baseline and the NL night.
Huang et al. Critical Care  (2015) 19:124 Page 7 of 11concentration was reached at about 1 h after melatonin
treatment, and then the melatonin concentration de-
creased with time. The average maximal serum concen-
tration (Cmax) in the NLM group was 1021.04 ±
50.58 pg/mL, which was significantly greater than in the
other groups (P <0.001).Figure 3 Serum melatonin concentration time profiles for
different study conditions on night 8. Serum melatonin levels
were measured at the end of the study period for 9 h from 20:50
to 06:00. The graph depicts the nocturnal serum melatonin
concentration. Points represent mean ± SD. Open circles, healthy
subjects on simulated ICU noise and light (NL); solid circles, healthy
subjects on NL plus placebo (NLP); solid triangles, healthy subjects
on NL plus use of earplugs and eye masks (NLEE); solid squares,
healthy subjects on NL plus melatonin (NLM): *P <0.05 at 22:00,
23:00, 0:00, 01:00, 02:00 and 03:00, respectively, for comparison
between the NLM and NL nights.Subjective sleep quality and anxiety levels
Table 4 shows that compared to the baseline night, sim-
ulated ICU noise and light led to worse subjective sleep
quality and higher anxiety levels (both P = 0.000). The
results were significant (all P = 0.000) for repeated mea-
sures ANOVA for subjective sleep quality and anxiety
levels on the simulated ICU noise and light night for
different study conditions (Table 5). Paired comparison
showed oral administration of melatonin and use of ear-
plugs and eye masks improved perceived sleep quality
notably (all P = 0.000), and NLM was better than NLEE
(P = 0.010). No difference was found in anxiety levels be-
tween the NLEE and NLM nights (P = 0.118) by paired
comparison, although SAI scores showed interesting
trends towards higher scores for the NLEE night.
Subjects’ evaluations of earplugs and eye masks
Subjects’ evaluations of earplugs and eye masks are listed
in Table 6. Overall, most of them rated the earplugs help-
ful to reduce noise, but uncomfortable and not easy to
use. Meanwhile, eye masks were considered to be com-
fortable, helpful and easy to use.
Safety and tolerance of melatonin
No adverse effects related to the drug were observed in
any subject during the study period.
Discussion
Consistent with previous studies in other samples [6,10,31],
we found that nocturnal sleep and body production of
melatonin are both disturbed in healthy subjects exposed
to simulated ICU noise and light, suggesting our protocol
was suitable to test our hypotheses. More importantly, we
noted that use of both oral melatonin, and earplugs and
eye masks improve sleep quality at different levels, espe-
cially melatonin.
In the first part of the study, our results confirmed
that in simulated ICU noise and light, healthy subjects
not only had greater anxiety and poorer subjective sleep
quality, but also suffered from the disturbance of sleep
structure, measured as shorter total sleep time, longer
sleep-onset latency, longer REM latency, more light sleep,
less REM sleep and more arousals and awakenings. Al-
though previous studies have suggested that ICU noise
disturbs the sleep quality of healthy subjects to varying de-
grees [10,31], only the research reported by Hu et al. wasTable 4 Subjective sleep quality and state anxiety between
baseline and simulated ICU noise and light night
Baseline NL P
State anxiety 29.7 ± 4.3 46.0 ± 8.8 0.000
Sleep quality 2.2 ± 1.0 5.7 ± 1.2 0.000
Baseline: quiet and dark environment; NL: simulated ICU noise and light.
Table 5 Subjective sleep quality and anxiety in simulated ICU noise and light night for different conditions
NL NLP NLEE NLM ANOVA Contrast 1 Contrast 2 Contrast 3
P P P P
State anxiety 46.0 ± 8.8 45.2 ± 7.7 33.5 ± 5.0 28.8 ± 3.3 0.000 0.000 0.000 0.118
Sleep quality 6.1 ± 1.0 4.3 ± 1.3 3.4 ± 0.8 2.2 ± 0.8 0.000 0.000 0.000 0.010
NL: simulated ICU noise and light; NLP: NL plus placebo; NLM: NL plus melatonin; NLEE: NL plus use of earplugs and eye masks; Contrast 1: NL vs. NLEE; Contrast
2: NLP vs. NLM; Contrast 3: NLEE vs. NLM.
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in a simulated ICU environment in a sleep laboratory [6].
Although the ICU environment might not be respon-
sible for the majority of ICU sleep disturbance, excessive
noise and long-lasting light have proved to be the import-
ant and inevitable factors and have negative physiological
and psychological effects on patients [9,34]. In some ICUs,
a single-bedded room has been chosen for noise reduc-
tion, however, most noise leaks from the main ICU [9].
Although mean sound and mean maximum sound inten-
sities are significantly reduced in a single-bedded room,
the frequency of sound spikes remained elevated so there
is still a lack of improvement in sleep continuity. Recent
emphasis has been on controlling noise level and encour-
aging the dimming of lights overnight in ICU settings, but
control of noise is not always possible, and lights are
always present in critical care for patient observations and
patient care activities [12]. Therefore, some domestic and
international experts recommend that the ICU incorpo-
rates earplugs/eye mask into routine nursing care [13]. In
the second part of our study, consistent with previous
studies, use of earplugs and eye masks significantly im-
proved the sleep quality, as seen in shorter sleep-onset la-
tency, reduced number of arousals and awakenings, better
perceived sleep quality and less anxiety. But the tolerabil-
ity of this intervention is critical. Previous studies showed
that some ICU patents were unwilling to use the earplugs
and/or eye masks because they found the intervention
uncomfortable [28]. In our study, most subjects who
wore earplugs and eye masks considered this strategy
was effective, however, the discomfort of earplugs is a
big problem. Some patients commented that there a
feeling of tightness, sore ears, claustrophobia and stillTable 6 Evaluation of earplugs and eye masks (n = 10)
One Two Three Four Five
Earplugs Comfort 3 4 2 1 0
Easy to apply 1 4 3 1 1
Effectiveness 0 1 3 4 2
Eye masks Comfort 0 1 2 5 2
Easy to apply 0 0 1 8 1
Effectiveness 0 1 6 2 1
One: very uncomfortable, very unhelpful, very awkward; Two: uncomfortable,
unhelpful, awkward; Three: satisfactory; Four: comfortable, helpful, easy to use;
Five: very comfortable, very helpful, very easy to use.being able to hear when using earplugs. So it is neces-
sary to explore other methods that are better tolerated
and even more effective.
An ideal sleep-improvement strategy for avoiding dis-
ruption of the ICU environment should be economical,
feasible, rapid in onset and offset, and without local or
systemic adverse effects. Recently, melatonin has raised
concerns among ICU experts. Melatonin is a key circa-
dian regulatory neurohormone mainly secreted by the
pineal gland. Light signals play the most important role
in the synthesis and secretion of melatonin in the organ-
ism via the retina and retina-hypothalamic pathways,
acting directly on the suprachiasmatic nuclei (SCN). So
melatonin secretion normally increases at night and de-
creases in the early morning hours. The melatonin rhythm
functions to synchronize circadian rhythms, whereas the
melatonin rhythm along with all other circadian rhythms
are synchronized by the central pacemaker. Therefore,
melatonin is a good sleep aid. The interest in melatonin
as a potential therapeutic or prophylactic agent in man-
agement of sleep disturbance in the ICU derives from
demonstrated low plasma concentrations and altered
secretion patterns of melatonin in the critically ill pa-
tients [23,24,27]. However, the physiological regulation
of melatonin secretion by darkness and light is abol-
ished in severely ill patients in ICU [14], so use of eye
masks or dimming the lights only might be not enough
to return to normal levels. Thus, supplementation of ex-
ogenous melatonin, to remodel the melatonin level in
the human body that approaches the physiological state,
might be a potential strategy for improving sleep among
ICU patients.
The second part of our study investigated and compared
the effect of oral melatonin and use of earplugs and eye
masks on sleep quality and serum melatonin level in a
simulated ICU noise and light environment. Both earplugs
and eye masks, and oral melatonin, significantly improved
sleep quality, in addition to shorter sleep-onset latency
and reduced number of arousals and awakenings; mela-
tonin also increased the duration of REM sleep stage and
total sleep time. Furthermore, when oral melatonin was
compared to wearing earplugs and eye masks, there was a
significant decrease in awakenings and arousals during
simulated ICU noise and light. The encouraging results
were established both by PSG and by participants’ self-
reports and showed that sleep in the simulated ICU noise
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masks, or after taking melatonin, was more restorative
and less fragmented. Although there is no consensus on
the relative functions of the various sleep stages, REM
sleep generally is considered to be important for cognitive
restoration [35]. On the other hand, both awakenings and
arousals, and acoustic events, can accelerate the heart rate,
which is linked to adverse cardiovascular events and may
impair the patient’s recuperation [36-38]. Compared to
earplugs and eye masks, melatonin administration might
benefit sleep better by three mechanisms: (1) although
earplugs can lower noise at a certain degree, the frequency
of sound spikes remained elevated, which is an important
contributor to noise-induced sleep disruption. However,
melatonin has some degree of sedative effect [39] and
might buffer the stress from noise. That is probably why
in our study melatonin administration without any inter-
vention for attenuating ambient noise improved sleep
under the noisy overnight sleep conditions; (2) some
patients considered the discomfort of earplugs and eye
masks to affect sleep quality; (3) wearing earplugs and
eye masks could not make the declined melatonin level
return to the normal level, but melatonin supplements
could bring a them to a higher level.
Although the cause of the low melatonin level in ICU
patients is still unclear, ICU noise and illumination should
be significant factors. In the study of Hu et al. simulated
nocturnal ICU noise and light caused low urinary secre-
tion levels of 6-sulphatoxymelatonin (6-SMT) and high
urinary cortisol during the night, and earplugs and eye
masks elevated the nocturnal levels of 6-SMT, which sug-
gests that raising the melatonin level might be one of the
mechanisms for improving sleep quality [6]. However, me-
tabolites of melatonin cannot entirely represent the true
level in the body [40].
There has been no study on the impact of ICU noise
and light on nocturnal serum melatonin levels. In nor-
mal physiological conditions, the melatonin peaks be-
tween 02:00 and 04:00, and troughs during daytime. The
average peak melatonin concentration at night is 60 pg/
mL, which gradually declines to trough levels of 10 pg/
mL during the daytime [15]. Our results for the baseline
night were similar to those values. In our study, ICU
noise and light significantly suppressed the melatonin
level and delayed the peak of melatonin, which also fits
with the retrospective study by Jamie et al., who found
that even small changes in ordinary light exposure
during the evening can significantly affect both plasma
melatonin concentrations and the entrained phase of the
human circadian pacemaker [41]. We also found that
although the subjects were exposed to light overnight,
the nocturnal melatonin level still maintained a certain
rhythm. Some investigators have speculated that the
regulation of melatonin secretion by direct control bythe environmental light-dark cycle has conferred on
humans an evolutionary advantage [42].
In our study, we found that administration of 1 mg of
fast-release melatonin was successful in achieving good
absorption. The mean maximal serum melatonin con-
centration was reached at about 1 h after administration,
which was close to 20 times higher than the NL-night
levels and 12 times higher than baseline levels, and then
the levels fell but still remained at a higher level than on
the NL, NLP and NLEE nights. Although oral melatonin
might result in 10 to 100 times the normal peak night-
concentration after ingestion, it has a wide safety margin
[29]. It is theoretically possible that high levels of mela-
tonin were achieved with a high dose at night, so that
even during the daytime, melatonin blood levels were
sufficiently high to promote diurnal sleep as well [29].
Daytime sleep would have then occurred and made noc-
turnal sleep more difficult. In addition, controlled release
formulations would bring an increased risk of prolonged
periods of supraphysiologic melatonin levels [43], there-
fore, we chose a relatively low dose of fast-released
melatonin for our study. However, after melatonin ad-
ministration the melatonin levels were lower than those
in previous studies, perhaps because of overnight illu-
mination exposure. The most suitable dose of melatonin
in critically ill patients in ICU should be confirmed fur-
ther, because Mistraletti et al. found that after adminis-
tration of indole the melatonin peak was reached earlier
in ICU patients than in healthy volunteers, and the rate
of melatonin disappearance was slightly slower [44]. In
our study, using earplugs and eye masks during the
simulated ICU noise and light elevated melatonin level
to some degree and advanced the timing of the clock.
However, the melatonin level was much lower than in
the melatonin group and that is one of the reasons why
melatonin has greater benefit on sleep in the simulated
ICU environment.
Our study design has some limitations, which should
be reviewed. First, the study was performed in a sleep
laboratory with healthy subjects rather than in an ICU
setting of critically ill patients, and therefore could not
completely simulate the full auditory and visual experi-
ence of the ICU. Second, the study was only performed
for a 9-h nocturnal period rather than over 24 h. The
ICU patients experience circadian rhythm disturbances
with sleep traversing the day and night. Therefore, an
ideal study should measure the sleep in healthy volun-
teers lying recumbent over a 24-h period to completely
simulate the ICU scenario. In addition, our sample sizes
were small, which limited the power of our statistical
analyses. Future studies with larger numbers and greater
diversity of participants would likely support these rec-
ommendations. Finally, although no adverse effects re-
lated to the oral melatonin were observed in our healthy
Huang et al. Critical Care  (2015) 19:124 Page 10 of 11subjects during the study period, the potential safety is-
sues related to melatonin administration in ICU patients
need to be considered, and the impact of oral melatonin
on critically ill patients with ICU sleep deprivation will
be our next study focus.
Conclusions
In summary, our results found that use of melatonin,
and earplugs and eye masks in healthy subjects in a sim-
ulated ICU environment not only improved subjective
sleep quality, but also improved the sleep structure, and
elevated nocturnal melatonin levels. Our pilot study pro-
vides a reasonable basis for promoting the use of oral
melatonin, and earplugs and eye masks for ICU patients.
However, compared to earplugs and eye masks, mela-
tonin showed better performance in effectiveness and
patient tolerability.
Key messages
 Nocturnal sleep and body production of melatonin
are both disturbed in healthy subjects with exposure
to simulated ICU noise and light
 Both oral melatonin and use of earplugs and eye
masks improve sleep quality at different levels,
especially melatonin
 Both oral melatonin and use of earplugs and eye
masks during simulated ICU noise and light elevates
melatonin levels to some degree, and advances the
timing of the clock. Melatonin is found to be much
more effective.
 The discomfort of earplugs and eye masks might
affect sleep quality, while no adverse effects of oral
melatonin have been observed in any patient during
the study period. Therefore, compared to earplugs
and eye masks, melatonin shows better performance
in effectiveness and patient tolerability.
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